Satala, C.-B.; Gurău, G.; Patrichi, G.; Gurau, A.-M.; Mehedinti, R.-C.; Leibovici, A.R.; Mihalache, D.
FGFR2b in Gastric Cancer: Translating a Therapeutic Target into a Reliable Biomarker. Cancers 2026, 18, 1863.
https://doi.org/10.3390/cancers18121863
AMA Style
Satala C-B, Gurău G, Patrichi G, Gurau A-M, Mehedinti R-C, Leibovici AR, Mihalache D.
FGFR2b in Gastric Cancer: Translating a Therapeutic Target into a Reliable Biomarker. Cancers. 2026; 18(12):1863.
https://doi.org/10.3390/cancers18121863
Chicago/Turabian Style
Satala, Catalin-Bogdan, Gabriela Gurău, Gabriela Patrichi, Alina-Mihaela Gurau, Roxana-Cristina Mehedinti, Andy Radu Leibovici, and Daniela Mihalache.
2026. "FGFR2b in Gastric Cancer: Translating a Therapeutic Target into a Reliable Biomarker" Cancers 18, no. 12: 1863.
https://doi.org/10.3390/cancers18121863
APA Style
Satala, C.-B., Gurău, G., Patrichi, G., Gurau, A.-M., Mehedinti, R.-C., Leibovici, A. R., & Mihalache, D.
(2026). FGFR2b in Gastric Cancer: Translating a Therapeutic Target into a Reliable Biomarker. Cancers, 18(12), 1863.
https://doi.org/10.3390/cancers18121863